PuraPharm Corporation Limited (1498.HK)
1498.HK Stock Price Chart
Explore PuraPharm Corporation Limited interactive price chart. Choose custom timeframes to analyze 1498.HK price movements and trends.
1498.HK Company Profile
Discover essential business fundamentals and corporate details for PuraPharm Corporation Limited (1498.HK) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
8 Jul 2015
Employees
479.00
Website
https://www.purapharm.comCEO
Yu Ling Chan
Description
PuraPharm Corporation Limited, an investment holding company, researches, develops, produces, and sells concentrated Chinese medicine granule (CCMG) and Chinese healthcare products in Hong Kong, Mainland China, and internationally. It operates through five segments: China CCMG, Hong Kong CCMG, Chinese Healthcare Products, Clinics, and Plantation. The company offers over the counter health products under the PuraGold, Haveron, Oncozac, and Immuzac names. It also provides Chinese medicine clinic management system for general clinic management; and operates Chinese medicine clinics under the Nong's name that provide Chinese medicine services and concentrated Chinese medicine granules products. In addition, the company engages in the plantation and trading of raw Chinese herbs; and manufacture and sale of traditional Chinese medicine decoction pieces. Further, it provides modernized Chinese medicine services; and Chinese medical diagnostic services. The company sells its products to hospitals, healthcare institutions, and medicine practitioners, as well as operates an online store. It operates 43 Nong's clinics in Hong Kong and 1 Nong's clinic in Guangxi, China. The company was founded in 1998 and is headquartered in Tai Po, Hong Kong.
1498.HK Financial Timeline
Browse a chronological timeline of PuraPharm Corporation Limited corporate events including earnings releases, dividend announcements, and stock splits.
Earnings released on 26 Aug 2025
Earnings released on 31 Mar 2025
EPS came in at -$0.04 , while revenue for the quarter reached $174.46M .
Earnings released on 28 Aug 2024
EPS came in at -$0.05 , while revenue for the quarter reached $207.63M .
Earnings released on 29 Mar 2024
EPS came in at -$0.17 , while revenue for the quarter reached $211.78M , missing expectations by -68.88%.
Earnings released on 30 Aug 2023
EPS came in at -$0.10 , while revenue for the quarter reached $195.08M , missing expectations by -71.33%.
Earnings released on 22 Mar 2023
EPS came in at -$0.20 , while revenue for the quarter reached $217.31M , missing expectations by -68.07%.
Earnings released on 28 Aug 2022
EPS came in at -$0.10 , while revenue for the quarter reached $230.76M , missing expectations by -66.09%.
Earnings released on 31 Dec 2021
EPS came in at -$0.34 falling short of the estimated $0.04 by -949.45%, while revenue for the quarter reached $356.84M , missing expectations by -15.66%.
Earnings released on 30 Jun 2021
EPS came in at $0.03 surpassing the estimated $0.02 by +51.80%, while revenue for the quarter reached $302.76M , missing expectations by -5.24%.
Earnings released on 31 Dec 2020
EPS came in at $0.05 surpassing the estimated $0.02 by +157.95%, while revenue for the quarter reached $321.38M , missing expectations by -12.79%.
1498.HK Stock Performance
Access detailed 1498.HK performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.